Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Other Non-Current Liabilities (2011 - 2025)

Siga Technologies' (SIGA) quarterly Other Non-Current Liabilities came in at $2.7 million in Q4 2025, down 17.1% on a YoY basis from $3.2 million in Q4 2024, and down 19.15% quarter-over-quarter from $3.3 million in Q3 2025.

Analysis

Siga Technologies (SIGA) Other Non-Current Liabilities (2011 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Other Non-Current Liabilities for 15 consecutive years, with $2.7 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities fell 17.1% year-over-year to $2.7 million; the trailing twelve-month figure through Dec 2025 stood at $2.7 million (down 17.1% YoY), and the FY2025 full-year result was $2.7 million, down 17.1% from the prior year.
  • Other Non-Current Liabilities declined to $2.7 million in Q4 2025 per SIGA's latest filing, from $3.3 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $6.5 million in Q4 2021 and bottomed at $2.7 million in Q4 2025.
  • Historically, Other Non-Current Liabilities has averaged $4.0 million across 5 years, with a median of $3.5 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities tumbled 48.51% in 2022, then climbed 7.93% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $6.5 million in 2021, then sank by 48.51% to $3.4 million in 2022, then rose by 0.54% to $3.4 million in 2023, then slipped by 5.2% to $3.2 million in 2024, then retreated by 17.1% to $2.7 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $2.7 million, $3.3 million, and $3.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn
10 Siga Technologies 235.60 Mn 80.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.65 Mn
Sep 30, 2025 3.28 Mn
Jun 30, 2025 3.30 Mn
Mar 31, 2025 3.13 Mn
Dec 31, 2024 3.20 Mn
Sep 30, 2024 3.61 Mn
Jun 30, 2024 3.72 Mn
Mar 31, 2024 3.34 Mn
Dec 31, 2023 3.38 Mn
Sep 30, 2023 3.50 Mn
Jun 30, 2023 3.45 Mn
Mar 31, 2023 3.35 Mn
Dec 31, 2022 3.36 Mn
Sep 30, 2022 3.63 Mn
Jun 30, 2022 3.48 Mn
Mar 31, 2022 6.17 Mn
Dec 31, 2021 6.52 Mn
Sep 30, 2021 6.34 Mn
Jun 30, 2021 5.30 Mn
Mar 31, 2021 5.72 Mn